Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel. - Jarvis BP; Holtyn AF; Subramaniam S; Tompkins DA; Oga EA; Bigelow G; Silverman K (Addiction (Abingdon, England), 2019)